Department of Cancer Genetics

Department head: Therese Sørlie
Department deputy head (adm): Gry Aarum Geitvik
Department secretary: Mona Hagen

Vision: Towards personalized therapy for cancer; integrated molecular and epidemiological studies to reduce risk, achieve early diagnosis, improve prognosis, and tailor the treatment for breast, lung, pancreatic and ovarian cancer.

The department’s overall research goals are:

Our goal is to follow the linear time course of predisposition, initiation, early stages and advanced disease and to dissect the molecular mechanisms triggered at each stage and to follow the multidimentional interactions at various levels in a systems biology approach to be able to better do risk estimation, prognostication and prediction.

To reach these goals we have divided our research into 7 activities:

  1. Gene environment interaction in cancer risk
  2. Tumor initiation and early diagnosis
  3. Tumor progression and metastasis
  4. Prediction of treatment response and targeted therapy
  5. Integrated approaches
  6. Functional validation
  7. Biostatistical challenges and approaches

Lab technology group

Lab technology group, headed by Gry Aarum Geitvik

Gry Aarum Geitvik


  • Using the best methods available to answer the scientific questions asked
  • Generate and maintain the biobank and data bases
  • Generate laboratory results of excellent quality
  • Highly educated and competent personnel that is up to date with recent innovations in laboratory methodology/technology
  Visit homepage


Contact information:

Department of Cancer Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo, Norway
Phone: +47 2278 1374, Fax: +47 2278 1395, Switchboard: +47 915 02770